Table 1. Demographic characteristics and risk factors of HCV antibody-positive participants.
IDU, Injection drug use; MSM, men who have sex with men.
| Characteristic | Total (N = 16) | HCV RNA positive (n = 8) | HCV RNA negative (n = 8) | P value |
| Demographics | ||||
| Age | ||||
| <40 | 1 (6 %) | 1 (12 %) | 0 (0 %) | |
| 40–49 | 11 (69 %) | 5 (63 %) | 6 (75 %) | |
| ≥50 | 4 (25 %) | 2 (25 %) | 2 (25 %) | |
| Gender | ||||
| Male | 10 (63 %) | 5 (63 %) | 5 (63 %) | |
| Female | 6 (37 %) | 3 (37 %) | 3 (37 %) | |
| Race | ||||
| African–American | 13 (81 %) | 6 (75 %) | 7 (88 %) | |
| Caucasian | 2 (13 %) | 2 (25 %) | 0 (0 %) | |
| Hispanic | 1 (6 %) | 0 (0 %) | 1 (12 %) | |
| Risk factor for HCV | ||||
| IDU | 0.608 | |||
| No | 10 (62 %) | 4 (50 %) | 6 (75 %) | |
| Yes | 6 (38 %) | 4 (50 %) | 2 (25 %) | |
| Trading sex in past 30 days | 0.010 | |||
| No | 8 (50 %) | 1 (12 %) | 7 (88 %) | |
| Yes | 8 (50 %) | 7 (88 %) | 1 (12 %) | |
| MSM in past 30 days | 0.200 | |||
| No | 13 (81 %) | 5 (63 %) | 8 (100 %) | |
| Yes | 3 (19 %) | 3 (37 %) | 0 (0 %) |